Kinarus Therapeutics vs Renibus Therapeutics Inc
Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocular diseases
5 employees · est. 2017 · Basel, Switzerland
Renibus Therapeutics Inc
A clinical-stage biotech company dedicated to transforming outcomes in cardiothoracic surgical patients
31 employees · est. 2016 · Southlake, United States
Renibus Therapeutics Inc is the older company (2017 vs 2016); Renibus Therapeutics Inc is the larger of the two.
Side-by-Side Comparison
| Metric | Kinarus Therapeutics | Renibus Therapeutics Inc |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | Basel, Switzerland | Southlake, United States |
| Employees | ||
| Employees | 5 | 31 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Series B |
| Total Funding | ||
| Total Funding | $36.55M | $214.72M |
| Funding Rounds | ||
| Funding Rounds | 6 | 8 |
| Services | ||
| Services | Not tracked yet | Development of biopharmaceutical products, Clinical trials for cardio, renal, and metabolic diseases, Pharmacologic preconditioning for post-op complications, Phase 3 clinical trials for new treatments |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with chronic kidney disease, Patients with metabolic acidosis, Patients undergoing cardiac surgery, Healthcare providers specializing in cardio, renal, and metabolic diseases |
| Taxonomy | ||
| Taxonomy | Clinical-stage Pharmaceutical CompanyDrug DevelopmentViral DiseasesRespiratory DiseasesOphthalmic DiseasesP38 MAPK Inhibitor +9 | Clinical-stage BiotechBiopharmaceuticalCardiorenal DiseasesCytoprotective PathwaysOrgan ProtectionRBT-1 +9 |
| Website | ||
| Website | kinarus.com | renibus.com |
About Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage pharmaceutical company based in Switzerland. Established in 2017, the company is dedicated to developing innovative treatments for viral, respiratory, and ophthalmic diseases. Their flagship drug candidate is an oral combination of a P38 mitogen-activated pro...
About Renibus Therapeutics Inc
Renibus Therapeutics Inc, founded in 2016, is a prominent player in the biotechnology and health care sectors based in the United States. The company focuses on transforming outcomes for cardiothoracic surgical patients, living up to its slogan as a clinical-stage biotech company. At the heart of R...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Kinarus Therapeutics and Renibus Therapeutics Inc for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Kinarus Therapeutics or Renibus Therapeutics Inc moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Kinarus Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kinarus Therapeutics on 12 Sep 2024, and Renibus Therapeutics Inc on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.